LLY

1,048.36

+1.39%↑

JNJ

244.28

+0.03%↑

ABBV

234.47

+4.3%↑

NVS

163.08

+1.41%↑

MRK

122.45

+0.88%↑

LLY

1,048.36

+1.39%↑

JNJ

244.28

+0.03%↑

ABBV

234.47

+4.3%↑

NVS

163.08

+1.41%↑

MRK

122.45

+0.88%↑

LLY

1,048.36

+1.39%↑

JNJ

244.28

+0.03%↑

ABBV

234.47

+4.3%↑

NVS

163.08

+1.41%↑

MRK

122.45

+0.88%↑

LLY

1,048.36

+1.39%↑

JNJ

244.28

+0.03%↑

ABBV

234.47

+4.3%↑

NVS

163.08

+1.41%↑

MRK

122.45

+0.88%↑

LLY

1,048.36

+1.39%↑

JNJ

244.28

+0.03%↑

ABBV

234.47

+4.3%↑

NVS

163.08

+1.41%↑

MRK

122.45

+0.88%↑

McKesson Corp

Отворен

СекторЗдравеопазване

923.18 -4.07

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

894.09

Максимум

966.46

Ключови измерители

By Trading Economics

Приходи

40M

1.3B

Продажби

3B

106B

P/E

Средно за сектора

27.781

121.746

Дивидентна доходност

0.32

Марж на печалбата

1.177

Служители

43,000

EBITDA

374M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+1.22% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.32%

2.26%

Следващи печалби

7.05.2026 г.

Следваща дата на дивидент

1.04.2026 г.

Следваща дата на екс-дивидент

2.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

13B

119B

Предишно отваряне

927.25

Предишно затваряне

923.18

Настроения в новините

By Acuity

39%

61%

127 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.02.2026 г., 23:57 ч. UTC

Горещи акции

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12.02.2026 г., 23:35 ч. UTC

Печалби
Значими двигатели на пазара

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12.02.2026 г., 23:28 ч. UTC

Печалби

Applied Materials Profit Rises on Soaring AI Demand -- Update

12.02.2026 г., 21:47 ч. UTC

Печалби

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13.02.2026 г., 00:00 ч. UTC

Пазарно говорене

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12.02.2026 г., 23:38 ч. UTC

Пазарно говорене

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12.02.2026 г., 23:33 ч. UTC

Печалби

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12.02.2026 г., 23:09 ч. UTC

Пазарно говорене

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12.02.2026 г., 22:55 ч. UTC

Печалби
Горещи акции

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12.02.2026 г., 22:46 ч. UTC

Пазарно говорене

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12.02.2026 г., 22:23 ч. UTC

Печалби

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12.02.2026 г., 22:15 ч. UTC

Печалби

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12.02.2026 г., 22:15 ч. UTC

Печалби

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12.02.2026 г., 22:15 ч. UTC

Печалби

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12.02.2026 г., 22:15 ч. UTC

Печалби

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12.02.2026 г., 22:00 ч. UTC

Печалби

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12.02.2026 г., 22:00 ч. UTC

Печалби

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12.02.2026 г., 22:00 ч. UTC

Печалби

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12.02.2026 г., 22:00 ч. UTC

Печалби

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12.02.2026 г., 22:00 ч. UTC

Печалби

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12.02.2026 г., 22:00 ч. UTC

Печалби

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12.02.2026 г., 21:57 ч. UTC

Печалби

XP 4Q Rev BRL4.95B >XP

12.02.2026 г., 21:52 ч. UTC

Печалби

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

12.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

12.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.02.2026 г., 21:47 ч. UTC

Печалби

Morningstar 4Q Rev $641M >MORN

12.02.2026 г., 21:39 ч. UTC

Печалби

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12.02.2026 г., 21:38 ч. UTC

Печалби

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

1.22% нагоре

12-месечна прогноза

Среден 974.09 USD  1.22%

Висок 1,107 USD

Нисък 885 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

11 ratings

9

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

127 / 352 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat